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Clinical course and risk factors for mortality of 
adult inpatients with COVID-19 in Wuhan, China: 
a retrospective cohort study
Zhou et al, The Lancet, Vol 395, Issue 10229, 28 Mar–3 Apr 2020, p 1054-1062
Goals: 
• Identify risk factors for mortality
• Describe clinical course and dynamics of viral 
shedding
Methods:
• Retrospective cohort study
• 2 hospitals
• Adults (≥18 y) who were either discharged or died between Dec 29, 2019 and 
Jan 31, 2020
Approved by Ethics Board
Informed consent waived
Methods (contd.)
• 4 institutions were involved with detection of SARS-CoV-2 – used 
next-generation seq or real-time RT-PCR
• Throat swabs for SARS-CoV-2 PCR every other day after remission of 
symptoms – only qualitative data
• Criteria for discharge – no fever x 3 d, improvement on chest CT, 2 
throat samples – at least 24 h apart – negative by PCR
• Blood tests – CBC, coagulation, serum chemistry, renal, hepatic, CPK, 
LDH, myocardial enzymes, D-dimer, IL-6 , ferritin, procalcitonin
Definitions
Fever – temp >37.3 (axillary)
Sepsis / septic shock – per Third international Consensus Definition for Sepsis 
and Septic Shock (described in next slide)
Definitions for secondary infection – clinical symptoms or signs of pneumonia 
or bacteremia, and +ve culture from lower resp tract or blood
Definitions of AKI, ARDS, cardiac injury, coagulopathy..
Illness severity of COVID-19 – according  to Chinese management guideline for 
COVID-19 (version 6.0)
Sepsis-related organ failure (SOFA) and quick SOFA (qSOFA) scores
SOFA score – Respiratory, CNS, cardiovascular, liver, coagulation and renal criteria. Scores of 0-4 assigned 
to  each criteria
Max SOFA score Mortality
0 – 6 <10%
7 – 9 15 – 20%
10 – 12 40 – 50%
13 – 14 50 – 60%
15 >80%
16 – 24 >90%
qSOFA score – bedside prompt that may identify patients with suspected 
infection who are at greater risk for a poor outcome outside the ICU.
Only 3 criteria - one point each for low blood pressure (SBP≤100 mmHg), high 
respiratory rate (≥22 breaths per min), or altered mentation (Glasgow coma 
scale<15) 
Statistical analysis
Continuous variable – presented as median (interquartile range [IQR])
Categorical variables – presented as number – n (%)
Comparisons between survivors and non-survivors – Mann-Whitney U test, Chi-square (χ2), 
or Fisher’s exact test
From Winters et al - Ochsner J. 2010 Fall; 10(3): 213–216.
Parametric Tests
• assume that sample data usually come from a normal (Gaussian) 
distribution requires a large sample size 
• differences between individual values in a sample and are more 
powerful
• able to identify smaller differences than are nonparametric tests 
and should be used whenever possible
Nonparametric Tests
• make no assumptions about the distribution of originating data
• therefore ignores absolute values of data points and focus instead 
on ordinal properties (eg, which is smallest, which is most 
common) 
• more difficult to demonstrate statistical significance with a 
nonparametric test (ie, the difference between the 2 groups must 




Risk factors associated with in-hospital death:
• Univariable (univariate) and Multivariable (multivariate) logistic 
regression models
Total number of deaths – 54. Thus only 5 variables were chosen (based on 
previous data) for multivariate analysis to avoid ‘overfitting’ (i.e., too many 
parameters for the data set). Focused on data that are likely to be readily 
available in emergency settings
Used generalized linear model adjust for possible differences in pt
characteristics and differences in Rx between the 2 centers
Results
Table 1. Demographic, clinical, lab and radiologic findings on admission
831 pts hospitalized with COVID-19  – 613 excluded (still hospitalized as of Jan 31, 2020, or not confirmed 
by SARS-CoV-2 RNA detection
Table 1. Demographic, clinical, lab 
and radiologic findings on 
admission
Table 1 (contd). Demographic, clinical, lab and radiologic findings on admission
Results
What is the utility of 
breaking the data down 
into ranges?
Table 1 (contd). Demographic, 
clinical, lab and radiologic 
findings on admission
Table 1 (contd). Demographic, clinical, lab and radiologic findings on admission
Results
Results
Table 2. Treatments and outcomes
Sicker patients likely 
to receive drugs and 
supportive treatment
Table 2. Treatments 
and outcomes
Table 3. Risk factors 
associated with in-
hospital death










• Fairly large numbers (largest to date)
• Two centers
• Identifies prognostic indicators of poor outcome/mortality despite ICU care – can this help 
allocation of resources during a crisis? Ethical dilemma! 
• Dynamics of viral shedding 
Limitations
• Retrospective study
• Not all patients had all the lab tests performed
• Various treatments tried in a non-controlled manner  - could influence outcomes
• Lack of quantitative SARS-CoV-2 measurements
• Findings in Wuhan may not necessarily apply to other populations
